04-03-2022, 08:15 AM
Sinovac has launched Phase III trials involving more than 10,000 participants who are children between 6 months and 17 years of age in South Africa, Malaysia, the Philippines and Chile, and it has initially shown a positive safety result.
https://www.globaltimes.cn/page/202203/1253824.shtml
https://www.globaltimes.cn/page/202203/1253824.shtml